Saturday, 17 October 2026European Markets

IDEX BIOMETRICS Stock Went Up By Over 12% So Far Today

Loading stream...

(VIANEWS) - Shares of IDEX BIOMETRICS (Oslo Børs Benchmark Index_GI: IDEX.OL) rose by a staggering 12.14% to kr0.97 at 13:38 EST on Wednesday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI is rising 0.2% to kr1,243.41, following the last session's upward trend. This seems, up to now, a somewhat up trend trading session today.

IDEX BIOMETRICS's last close was kr0.85, 61.26% below its 52-week high of kr2.19.

About IDEX BIOMETRICS

IDEX Biometrics ASA engages in the design, development, and sale of fingerprint authentication solutions in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless financial payment, access control, and smart cards, as well as card-based devices for the storage of digital currencies. It primarily serves manufacturers of smart cards for financial payment applications and biometric payment card markets. IDEX Biometrics ASA was incorporated in 1996 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, IDEX BIOMETRICS has a trailing twelve months EPS of kr-0.51.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -107.86%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IDEX BIOMETRICS's stock is considered to be overbought (>=80).

Earnings Before Interest, Taxes, Depreciation, and Amortization

IDEX BIOMETRICS's EBITDA is -68.72.

Volume

Today's last reported volume for IDEX BIOMETRICS is 4450088 which is 8.75% below its average volume of 4876880.

More news about IDEX BIOMETRICS (IDEX.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com